Följ
Cedric Shuai Cui
Cedric Shuai Cui
Andra namnShuai Cui
Postdoctoral Research Fellow in Pharmacology, immunology and Neuroscience, The University of
Verifierad e-postadress på uq.edu.au
Titel
Citeras av
Citeras av
År
Intrinsic bias at non-canonical, β-arrestin-coupled seven transmembrane receptors
S Pandey, P Kumari, M Baidya, R Kise, Y Cao, H Dwivedi-Agnihotri, ...
Molecular cell 81 (22), 4605-4621. e11, 2021
722021
CD8+ lineage dendritic cells determine adaptive immune responses to inflammasome activation upon sterile skin injury
R Chakraborty, J Chandra, S Cui, L Tolley, MA Cooper, M Kendall, ...
Experimental Dermatology 27 (1), 71-79, 2018
122018
Development of potent and selective agonists for complement C5a receptor 1 with in vivo activity
DM Gorman, XX Li, JD Lee, JN Fung, CS Cui, HS Lee, BE Rolfe, ...
Journal of Medicinal Chemistry 64 (22), 16598-16608, 2021
102021
In vivo pharmacodynamic method to assess complement C5a receptor antagonist efficacy
CS Cui, V Kumar, DM Gorman, RJ Clark, JD Lee, TM Woodruff
ACS Pharmacology & Translational Science 5 (1), 41-51, 2021
42021
Development of Synthetic Human and Mouse C5a: Application to Binding and Functional Assays In Vitro and In Vivo
DM Gorman, XX Li, CD Payne, CS Cui, JD Lee, KJ Rosengren, ...
ACS Pharmacology & Translational Science 4 (6), 1808-1817, 2021
42021
Success in Navigating Hurdles to Oral Delivery of a Bioactive Peptide Complement Antagonist through Use of Nanoparticles to Increase Bioavailability and In Vivo Efficacy
W Xu, V Kumar, CS Cui, XX Li, AK Whittaker, ZP Xu, MT Smith, ...
Advanced Therapeutics 5 (12), 2200109, 2022
32022
Optimisation of a Microfluidic Method for the Delivery of a Small Peptide
FY Han, W Xu, V Kumar, CS Cui, X Li, X Jiang, TM Woodruff, AK Whittaker, ...
Pharmaceutics 13 (9), 1505, 2021
32021
Success in Navigating Hurdles to Oral Delivery of a Bioactive Peptide Complement Antagonist through Use of Nanoparticles to Increase Bioavailability and In Vivo Efficacy (Adv …
W Xu, V Kumar, CS Cui, XX Li, AK Whittaker, ZP Xu, MT Smith, ...
Advanced Therapeutics 5 (12), 2270030, 2022
2022
An in-vivo pharmacodynamic method to investigate complement C5a receptor antagonists
C Cui, V Kumar, D Gorman, R Clark, J Lee, T Woodruff
MOLECULAR IMMUNOLOGY 141, 125-126, 2022
2022
Sustained-release ketamine-loaded lipid-particulate system: in vivo assessment in mice
W Xu, F Maqbool, V Kumar, JR Falconer, CS Cui, TM Woodruff, K Borges, ...
Drug Delivery and Translational Research, 1-9, 2021
2021
Optimisation of a Microfluidic Method for the Delivery of a Small Peptide. Pharmaceutics 2021, 13, 1505
FY Han, W Xu, V Kumar, CS Cui, X Li, X Jiang, TM Woodruff, AK Whittaker, ...
Nanomedicine Formulations Based on PLGA Nanoparticles for Diagnosis …, 2021
2021
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–11